Correlation Between Biomarin Pharmaceutical and Assembly Biosciences
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Assembly Biosciences, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Assembly Biosciences.
Diversification Opportunities for Biomarin Pharmaceutical and Assembly Biosciences
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Biomarin and Assembly is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Assembly Biosciences go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and Assembly Biosciences
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Assembly Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 2.66 times less risky than Assembly Biosciences. The stock trades about -0.04 of its potential returns per unit of risk. The Assembly Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,908 in Assembly Biosciences on August 31, 2024 and sell it today you would lose (204.00) from holding Assembly Biosciences or give up 10.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.79% |
| Values | Daily Returns |
Biomarin Pharmaceutical vs. Assembly Biosciences
Performance |
| Timeline |
| Biomarin Pharmaceutical |
| Assembly Biosciences |
Biomarin Pharmaceutical and Assembly Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomarin Pharmaceutical and Assembly Biosciences
The main advantage of trading using opposite Biomarin Pharmaceutical and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
| Assembly Biosciences vs. Spero Therapeutics | Assembly Biosciences vs. Achilles Therapeutics PLC | Assembly Biosciences vs. Instil Bio | Assembly Biosciences vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |